Small cell lung cancer (SCLC) is a malignant solid tumor. In recent years, although immune check point inhibitors (ICIs) have achieved important advances in the treatment of SCLC, immune-related adverse events (irAEs) have occurred at the same time during the therapeutic period. Some irAEs lead to dose reduction or treatment rejection. The immune…[Read more]

This study has revealed a mechanism by which lipid metabolites control macrophage activation and function, modification of which could lead to a new therapeutic approach for MS and other inflammatory disorders.The activation and degranulation of mast cells is critical in the pathogenesis of allergic inflammation and modulation of inflammation.…[Read more]

dorsalis only. Synthetic blends of these compounds were found to attract female and male B. dorsalis in laboratory as well as field conditions. Using specific cues common to each set, a blend of methyl 3-methylbutanoate, butyl acetate, 3-methylbutyl acetate and hexyl acetate attracted both sexes of B dorsalis. This study demonstrates the use of…[Read more]

05) between FSF and the SF. There was also a significant reduction while comparing the metal removal in treatments after the second and eighth days. The general affinity range for iron in the four treatments was 30 > 40 > SF > 50, in that order has 94.26, 91.66, 87.98 and 85.48 as removal efficiency for iron (5 mg L-1) on the eighth day. P.…[Read more]